Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:1005-1012
Published online before print February 9, 2009, doi: 10.1161/CIRCULATIONAHA.108.765701
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/7/1005    most recent
CIRCULATIONAHA.108.765701v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halcox, J. P.J.
Right arrow Articles by Deanfield, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halcox, J. P.J.
Right arrow Articles by Deanfield, J. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Imaging
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
Right arrowRelated Article

(Circulation. 2009;119:1005-1012.)
© 2009 American Heart Association, Inc.


Vascular Medicine

Endothelial Function Predicts Progression of Carotid Intima-Media Thickness

Julian P.J. Halcox, MA, MD, FRCP; Ann E. Donald, AVS; Elizabeth Ellins, MA; Daniel R. Witte, PhD; Martin J. Shipley, MSc; Eric J. Brunner, PhD; Michael G. Marmot, PhD, FRCP; John E. Deanfield, MB, FRCP

From the Department of Cardiology, Cardiff University (J.P.J.H.); Vascular Physiology Unit, Institute of Child Health (J.P.J.H., A.E.D., E.E., J.E.D.); and Department of Epidemiology and Public Health, University College (D.R.W., M.J.S., E.J.B., M.G.M.), London, UK.

Correspondence to Professor John Deanfield, Vascular Physiology Unit, Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, 30 Guilford St, London WC1N 3EH, UK. E-mail j.deanfield{at}ich.ucl.ac.uk

Received January 22, 2008; accepted December 10, 2008.

Background— Endothelial dysfunction develops early and has been shown to predict the development of clinical complications of atherosclerosis. However, the relationship between early endothelial dysfunction and the progression of arterial disease in the general population is unknown. We investigated endothelial dysfunction, risk factors, and progression of carotid intima-media thickness (cIMT) in late-middle-aged individuals at low to intermediate cardiovascular risk in a prospective study between 1997 and 2005.

Methods and Results— Brachial artery flow-mediated dilatation and cIMT were measured in 213 nonsmoking British civil servants recruited from a prospective cohort (Whitehall II study). Participants (age, 45 to 66 years) were free of clinical cardiovascular disease and diabetes mellitus. Risk factors and Framingham Risk Score were determined at baseline. cIMT was repeated 6.2±0.4 years later. At baseline, age, blood pressure, low-density lipoprotein cholesterol, and Framingham Risk Score correlated with cIMT. However, only flow-mediated dilatation, not risk factors or Framingham Risk Score, was associated with average annual progression of cIMT. This relationship remained significant after adjustment for risk factors whether entered as separate variables or as Framingham Risk Score. Further adjustment for waist circumference, triglycerides, and employment grade had no significant effect.

Conclusions— Systemic endothelial function was associated with progression of preclinical carotid arterial disease over a 6-year period and was more closely related to cIMT changes than conventional risk factors. Thus, the relationship between endothelial dysfunction and adverse outcome is likely to be due not only to destabilization of established disease in high-risk populations but also to its impact on the evolution of the atherosclerotic substrate. Flow-mediated dilatation testing provides an integrated vascular measure that may aid the prediction of structural disease evolution and represents a potential short- to intermediate-term outcome measure for evaluation of preventive treatment strategies.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 119: 909-911. [Extract] [Full Text]



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
G. Atkinson, A. M. Batterham, M. A. Black, N. T. Cable, N. D. Hopkins, E. A. Dawson, D. H. J. Thijssen, H. Jones, T. M. Tinken, and D. J. Green
Is the ratio of flow-mediated dilation and shear rate a statistically sound approach to normalization in cross-sectional studies on endothelial function?
J Appl Physiol, December 1, 2009; 107(6): 1893 - 1899.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
A. Bass, A. L Hinderliter, and C. R Lee
The Impact of Ezetimibe on Endothelial Function and Other Markers of Cardiovascular Risk
Ann. Pharmacother., December 1, 2009; 43(12): 2021 - 2030.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
C. Heiss, J. Balzer, T. Hauffe, S. Hamada, E. Stegemann, T. Koeppel, M. W. Merx, T. Rassaf, M. Kelm, and T. Lauer
Vascular Dysfunction of Brachial Artery After Transradial Access for Coronary Catheterization: Impact of Smoking and Catheter Changes
J. Am. Coll. Cardiol. Intv., November 1, 2009; 2(11): 1067 - 1073.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P. M Freeman and J. P J Halcox
Vascular impact of progenitor cell mobilisation for cardiac repair post-myocardial infarction
Heart, August 15, 2009; 95(16): 1301 - 1302.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
J.-C. Tardif
Angiotensin-converting enzyme inhibitors and atherosclerotic plaque: a key role in the cardiovascular protection of patients with coronary artery disease
Eur. Heart J. Suppl., August 1, 2009; 11(suppl_E): E9 - E16.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Ganz, J. E. Ho, and P. Y. Hsue
Structural and functional manifestations of human atherosclerosis: do they run in parallel?
Eur. Heart J., July 1, 2009; 30(13): 1556 - 1558.
[Full Text] [PDF]


Home page
CirculationHome page
J. Steffel and T. F. Luscher
Predicting the Development of Atherosclerosis
Circulation, February 24, 2009; 119(7): 919 - 921.
[Full Text] [PDF]